GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » 12-1 Month Momentum %

Diamyd Medical AB (OSTO:DMYD B) 12-1 Month Momentum % : 35.88% (As of May. 29, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-29), Diamyd Medical AB's 12-1 Month Momentum % is 35.88%.

The industry rank for Diamyd Medical AB's 12-1 Month Momentum % or its related term are showing as below:

OSTO:DMYD B's 12-1 Month Momentum % is ranked better than
84.41% of 1475 companies
in the Biotechnology industry
Industry Median: -25 vs OSTO:DMYD B: 35.88

Competitive Comparison of Diamyd Medical AB's 12-1 Month Momentum %

For the Biotechnology subindustry, Diamyd Medical AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's 12-1 Month Momentum % falls into.



Diamyd Medical AB  (OSTO:DMYD B) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamyd Medical AB  (OSTO:DMYD B) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Diamyd Medical AB 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB (OSTO:DMYD B) Business Description

Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB (OSTO:DMYD B) Headlines

No Headlines